Global Anatomic Pathology Market Size, Share & Trend Analysis- By Product, By Application, By Technique, By End User, Regional Outlook, Competitive Tactics, and Segment Forecast to 2031.

The Global Anatomic Pathology Market size was estimated at USD XX billion in 2021 and is expected to hit around USD XX billion by 2031, poised to grow at a compound annual growth rate (CAGR) of XX% from 2022 to 2031.

Global Anatomic Pathology Market: Breakup by Region, 2022 & 2031

Diagram Description automatically generated with low confidence

Source: Primary Research and Secondary Research Analysis

The term "global anatomic pathology market" designates the area that deals with the analysis of tissue samples taken from biopsies, operations, or autopsies in order to diagnose and investigate diseases. Analysing organs, tissues, and cells is part of anatomic pathology, which aims to recognise and classify diseases, assess their severity, and offer insights into the best course of action.

This market covers a range of approaches and techniques for examining and interpreting tissue samples, including histology, cytology, immunohistochemistry, molecular pathology, and electron microscopy. It also includes a variety of equipment, chemicals, and consumables used in labs to process, stain, image, and analyse samples.

Several noteworthy trends are being observed in the anatomic pathology industry on a global scale. One noteworthy development is the expanding use of digital pathology technologies, which are revolutionising the industry by making it possible to digitise, store, and analyse tissue samples. For increased diagnostic effectiveness and efficiency, digital pathology enables remote access to pictures, pathologists' collaboration, and integration with artificial intelligence systems.

Download Free Sample Report

The incorporation of molecular pathology methods, such as next-generation sequencing, with standard anatomic pathology procedures is another development. This makes it possible to analyse genetic changes, biomarkers, and patient treatment options in great detail. The use of molecular diagnostics is particularly important in the field of oncology, where precision medicine and targeted medicines are rising in popularity.

In addition, quality assurance and standardisation are becoming increasingly important in anatomic pathology practises in order to reduce errors, enhance patient outcomes, and guarantee reproducibility of results. This include the use of standardised procedures, programmes for testing proficiency, and accrediting procedures.

Market Segmentation:

Market Breakup: By Product

  • Instruments
  • Consumables
  • Software

Market Breakup: By Application

  • Disease Diagnosis
  • Cancer Diagnostics
  • Drug Discovery And Development
  • Research
  • Forensic Pathology

Market Breakup: By Technique

  • Histology
  • Cytology
  • Immunohistochemistry
  • Molecular Pathology
  • Electron Microscopy

Market Breakup: By End User

  • Hospitals
  • Diagnostic Laboratories
  • Academic And Research Institutions
  • Pharmaceutical Companies

Regional Analysis

The size and scope of the global Anatomic Pathology industry vary by region and are important and expanding. Below is a quick summary of the industry's regional analysis:

North America: The anatomic pathology market is dominated by the North American region, which includes the United States and Canada. This is because of factors including a developed healthcare infrastructure, cutting-edge diagnostic tools, and high healthcare costs. Automation, molecular diagnostics, and digital pathology are being widely adopted in the region. In addition, the existence of significant market participants, research organisations, and academic institutions supports the expansion of the industry in North America.

Europe: Another significant market for anatomic pathology is Europe, which is led by nations like Germany, the United Kingdom, France, and Italy. Market expansion is fuelled by elements like rising cancer incidence, an ageing population, and supportive government measures to support improved diagnostics and personalised medicine. The region also has a substantial uptake of molecular pathology and digital pathology methods.

Asia-Pacific: The anatomic pathology market is expanding quickly in the Asia-Pacific area. A growing number of nations, including China, Japan, India, and South Korea, are making bigger expenditures in their healthcare infrastructure and placing more emphasis on enhancing the quality of their medical services. Due to a huge patient population, an increase in the prevalence of chronic diseases, and rising healthcare costs, the region offers tremendous growth potential.

South America: Brazil is the main driver of the expansion of the anatomic pathology market in South America, which is a developing market. The market is being driven by factors such as rising cancer and infectious disease incidence, bettering healthcare infrastructure, and increased public knowledge of cutting-edge diagnostic methods. To improve diagnostic capabilities, the region is investing in laboratory infrastructure and implementing digital pathology solutions.

Middle East & Africa: varied countries in this region have varied market trends. Growing populations, rising healthcare costs, and developing infrastructure in the healthcare industry all contribute to market expansion. The market in this region is still growing, and obstacles including the lack of access to cutting-edge healthcare facilities and diagnostic services could have an influence. In the area, initiatives are being made to improve disease diagnostics and boost the healthcare system.

Market Breakup By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape

The Anatomic Pathology Industry competitive landscape provides details by competitor. Details included are company outline, company financials, revenue generated, market potential, investment in research and development, new market initiatives, worldwide occurrence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The overhead data points providing are only related to the businesses’ focus related to Anatomic Pathology marketplace.

Major players operating in the Global Anatomic Pathology Industry are:

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • Sakura Finetek USA, Inc.
  • BioGenex Laboratories, Inc.
  • Merck KGaA
  • Sysmex Corporation
  • Hologic, Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings (LabCorp)
  • NEOGENOMICS, Inc.
  • Royal Philips N.V.
  • Bio-Rad Laboratories, Inc.

Table of Content

Global Anatomic Pathology Industry Research Report, 2020-2031.

  1. 1. Introduction
    1. Report description
    2. Key market segments
    3. Regional Scope
    4. Executive Summary
  2. 2. Research Methodology
    1. Secondary Research
    2. Primary Research
    3. Secondary Analyst Tools and Models
  3. 3. Market Dynamics
    1. Market driver analysis
    2. Market restraint analysis
    3. Market Opportunity   
    4. Market Challenges
    5. Impact analysis of COVID-19 on the Anatomic Pathology Industry
  4. 4. Market Variables and Outlook
    1. SWOT Analysis
      1. Strengths
      2. Weaknesses
      3. Opportunities
      4. Threats
    2. Supply Chain Analysis
    3. PESTEL Analysis
      1. Political Landscape
      2. Economic Landscape
      3. Social Landscape
      4. Technological Landscape
      5. Environmental Landscape
      6. Legal Landscape
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitute
      4. Threat of New Entrant
      5. Competitive Rivalry
  5. 5. Anatomic Pathology Industry: Product Estimates & Trend Analysis
    1. Anatomic Pathology Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Instruments
      1. Market Size & Forecast, 2020-2031
    4. Consumables
      1. Market Size & Forecast, 2020-2031
    5. Software
      1. Market Size & Forecast, 2020-2031

 

  1. 6. Anatomic Pathology Industry: Application Estimates & Trend Analysis
    1. Anatomic Pathology Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Disease Diagnosis
      1. Market Size & Forecast, 2020-2031
    4. Cancer Diagnostics
      1. Market Size & Forecast, 2020-2031
    5. Drug Discovery And Development
      1. Market Size & Forecast, 2020-2031
    6. Research
      1. Market Size & Forecast, 2020-2031
    7. Forensic Pathology
      1. Market Size & Forecast, 2020-2031
  2. 7. Anatomic Pathology Industry: Technique Size Estimates & Trend Analysis
    1. Anatomic Pathology Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Histology
      1. Market Size & Forecast, 2020-2031
    4. Cytology
      1. Market Size & Forecast, 2020-2031
    5. Immunohistochemistry
      1. Market Size & Forecast, 2020-2031
    6. Molecular Pathology
      1. Market Size & Forecast, 2020-2031
    7. Electron Microscopy
      1. Market Size & Forecast, 2020-2031
  3. 8. Anatomic Pathology Industry: End User Estimates & Trend Analysis
    1. Anatomic Pathology Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Hospitals
      1. Market Size & Forecast, 2020-2031
    4. Diagnostic Laboratories
      1. Market Size & Forecast, 2020-2031
    5. Academic And Research Institutions
      1. Market Size & Forecast, 2020-2031
    6. Pharmaceutical Companies
      1. Market Size & Forecast, 2020-2031
  4. 9. Anatomic Pathology Industry: Regional Estimates & Trend Analysis
    1. Anatomic Pathology Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. North America
      1. Market Size & Forecast, 2020-2031
    4. Europe
      1. Market Size & Forecast, 2020-2031
    5. Asia Pacific
      1. Market Size & Forecast, 2020-2031
    6. Middle East & Africa
      1. Market Size & Forecast, 2020-2031
    7. Latin America
      1. Market Size & Forecast, 2020-2031
  5. 10. Anatomic Pathology Industry: Country Estimates & Trend Analysis
    1. Anatomic Pathology Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. U.S.
      1. Market Size & Forecast, 2020-2031
    4. Canada
      1. Market Size & Forecast, 2020-2031
    5. Mexico
      1. Market Size & Forecast, 2020-2031
    6. UK
      1. Market Size & Forecast, 2020-2031
    7. France
      1. Market Size & Forecast, 2020-2031
    8. Germany
      1. Market Size & Forecast, 2020-2031
    9. Russia
      1. Market Size & Forecast, 2020-2031
    10. Italy
      1. Market Size & Forecast, 2020-2031
    11. Spain
      1. Market Size & Forecast, 2020-2031
    12. China
      1. Market Size & Forecast, 2020-2031
    13. India
      1. Market Size & Forecast, 2020-2031
    14. Japan
      1. Market Size & Forecast, 2020-2031
    15. Indonesia
      1. Market Size & Forecast, 2020-2031
    16. South Korea
      1. Market Size & Forecast, 2020-2031
    17. Australia
      1. Market Size & Forecast, 2020-2031
    18. Brazil
      1. Market Size & Forecast, 2020-2031
    19. Argentina
      1. Market Size & Forecast, 2020-2031
    20. Saudi Arabia
      1. Market Size & Forecast, 2020-2031
    21. UAE
      1. Market Size & Forecast, 2020-2031
    22. South Africa
      1. Market Size & Forecast, 2020-2031
  6. 11. Competitive Landscape
    1. Company Market Share Analysis
    2. Vendor Landscape
    3. Competition Dashboard
  7. 12. Company Profiles
    1. Business Overview, Product Landscape, Financial Performanceand Company Strategies for below companies
    2.     F. Hoffmann-La Roche Ltd.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    3. Danaher Corporation
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    4. Thermo Fisher Scientific Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    5. Agilent Technologies, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    6. Abbott Laboratories
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    7. Sakura Finetek USA, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    8. BioGenex Laboratories, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    9. Merck KGaA
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    10. Sysmex Corporation
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    11. Hologic, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    12. Quest Diagnostics Incorporated
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    13. Laboratory Corporation of America Holdings (LabCorp)
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    14. NEOGENOMICS, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    15. Royal Philips N.V.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    16. Bio-Rad Laboratories, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
  8. 13. Conclusion


In case you don’t find what, you are looking for, please get in touch with our custom research team at sales@organicmarketresearch.com or Download Free Sample Report

  • Buy Now

Speak To Consultant

or Face to Face Meeting

Why Choose Us

  • 24x7 Post-Sales Support
  • 4000+ Reports Repository
  • 10% Free Customization
  • Large Network Of Industry Experts
  • Deep Sector Specific Intelligence
  • Unique Mix Of Global, Regional And Country Specific Reports

Related Reports

Recent News

Why Buy From Us?

Succeed

Our reports with in-depth insights will equip you to succeed in your business plans.

Instant Access

Get instant access to the information you need to make the right decision.

Opportunities

Explore where opportunities lie for you and mitigate the risks.

Trusted

We are one of the most trusted brands setting benchmarks of excellence.